Scancell Holdings PLC (AIM:SCLP, OTC:SCNLF, FRA:SCP), the developer of cancer immunotherapies, is pressing ahead with plans to list on the Nasdaq stock exchange following an all-share merger with US biotech Neuphoria Therapeutics, announced in July. The combined company will trade under the...
This is the newest page. Registered accounts read further back.